N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine

C111H201N13O3 — CID 167672057

IUPACN-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine
SMILESCC(C)C1CCC(N2CCN(C(C)C)CC2)C1.CC(C)N1CCC(N(C)C2CCC(C(C)(C)C)CC2)CC1.CC(C)N1CCN(C(=O)N2CC3CN(C(C)C)CC3C2)CC1.CC(C)OC1CC(N(CC2CCC(C(C)(C)C)CC2)C(C)C)C1.CC(C)OC1CC(N(CC2CN(C(C)C)C2)C(C)C)C1.CC(C)c1ccc(-c2ccc(-c3cnc(C(C)C)n3C)cc2)cc1
InChIInChI=1S/C22H26N2.C21H41NO.C19H38N2.C17H32N4O.C17H34N2O.C15H30N2/c1-15(2)17-6-8-18(9-7-17)19-10-12-20(13-11-19)21-14-23-22(16(3)4)24(21)5;1-15(2)22(19-12-20(13-19)23-16(3)4)14-17-8-10-18(11-9-17)21(5,6)7;1-15(2)21-13-11-18(12-14-21)20(6)17-9-7-16(8-10-17)19(3,4)5;1-13(2)18-5-7-19(8-6-18)17(22)21-11-15-9-20(14(3)4)10-16(15)12-21;1-12(2)18-9-15(10-18)11-19(13(3)4)16-7-17(8-16)20-14(5)6;1-12(2)14-5-6-15(11-14)17-9-7-16(8-10-17)13(3)4/h6-16H,1-5H3;15-20H,8-14H2,1-7H3;15-18H,7-14H2,1-6H3;13-16H,5-12H2,1-4H3;12-17H,7-11H2,1-6H3;12-15H,5-11H2,1-4H3
InChIKeyUGKOFOCCYLQWET-UHFFFAOYSA-N
MW1765.92 g/mol
LogP23.14
Rot. Bonds25

About N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine

N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine (PubChem CID 167672057) has the molecular formula C111H201N13O3 and a molecular weight of 1765.92 g/mol. Its IUPAC name is N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine.

Molecular Properties

Compound NameN-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine
PubChem CID167672057
Molecular FormulaC111H201N13O3
Molecular Weight1765.92 g/mol
Exact Mass1764.60
IUPAC NameN-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine
SMILESCC(C)C1CCC(N2CCN(C(C)C)CC2)C1.CC(C)N1CCC(N(C)C2CCC(C(C)(C)C)CC2)CC1.CC(C)N1CCN(C(=O)N2CC3CN(C(C)C)CC3C2)CC1.CC(C)OC1CC(N(CC2CCC(C(C)(C)C)CC2)C(C)C)C1.CC(C)OC1CC(N(CC2CN(C(C)C)C2)C(C)C)C1.CC(C)c1ccc(-c2ccc(-c3cnc(C(C)C)n3C)cc2)cc1
InChIInChI=1S/C22H26N2.C21H41NO.C19H38N2.C17H32N4O.C17H34N2O.C15H30N2/c1-15(2)17-6-8-18(9-7-17)19-10-12-20(13-11-19)21-14-23-22(16(3)4)24(21)5;1-15(2)22(19-12-20(13-19)23-16(3)4)14-17-8-10-18(11-9-17)21(5,6)7;1-15(2)21-13-11-18(12-14-21)20(6)17-9-7-16(8-10-17)19(3,4)5;1-13(2)18-5-7-19(8-6-18)17(22)21-11-15-9-20(14(3)4)10-16(15)12-21;1-12(2)18-9-15(10-18)11-19(13(3)4)16-7-17(8-16)20-14(5)6;1-12(2)14-5-6-15(11-14)17-9-7-16(8-10-17)13(3)4/h6-16H,1-5H3;15-20H,8-14H2,1-7H3;15-18H,7-14H2,1-6H3;13-16H,5-12H2,1-4H3;12-17H,7-11H2,1-6H3;12-15H,5-11H2,1-4H3
InChIKeyUGKOFOCCYLQWET-UHFFFAOYSA-N
XLogP23.14
TPSA88.99 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds25
Heavy Atoms127
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001765.92
LogP ≤ 523.14
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Analyze N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine?
The IUPAC name of N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine (CID 167672057) is N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine.
What is the SMILES notation for N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine?
The canonical SMILES for N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine is CC(C)C1CCC(N2CCN(C(C)C)CC2)C1.CC(C)N1CCC(N(C)C2CCC(C(C)(C)C)CC2)CC1.CC(C)N1CCN(C(=O)N2CC3CN(C(C)C)CC3C2)CC1.CC(C)OC1CC(N(CC2CCC(C(C)(C)C)CC2)C(C)C)C1.CC(C)OC1CC(N(CC2CN(C(C)C)C2)C(C)C)C1.CC(C)c1ccc(-c2ccc(-c3cnc(C(C)C)n3C)cc2)cc1.
What is the InChIKey of N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine?
The InChIKey is UGKOFOCCYLQWET-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26N2.C21H41NO.C19H38N2.C17H32N4O.C17H34N2O.C15H30N2/c1-15(2)17-6-8-18(9-7-17)19-10-12-20(13-11-19)21-14-23-22(16(3)4)24(21)5;1-15(2)22(19-12-20(13-19)23-16(3)4)14-17-8-10-18(11-9-17)21(5,6)7;1-15(2)21-13-11-18(12-14-21)20(6)17-9-7-16(8-10-17)19(3,4)5;1-13(2)18-5-7-19(8-6-18)17(22)21-11-15-9-20(14(3)4)10-16(15)12-21;1-12(2)18-9-15(10-18)11-19(13(3)4)16-7-17(8-16)20-14(5)6;1-12(2)14-5-6-15(11-14)17-9-7-16(8-10-17)13(3)4/h6-16H,1-5H3;15-20H,8-14H2,1-7H3;15-18H,7-14H2,1-6H3;13-16H,5-12H2,1-4H3;12-17H,7-11H2,1-6H3;12-15H,5-11H2,1-4H3.
What are the key properties of N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine?
N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine has a molecular weight of 1765.92 g/mol, XLogP of 23.14, 25 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-tert-butylcyclohexyl)-N-methyl-1-propan-2-ylpiperidin-4-amine;N-[(4-tert-butylcyclohexyl)methyl]-N-propan-2-yl-3-propan-2-yloxycyclobutan-1-amine;1-methyl-2-propan-2-yl-5-[4-(4-propan-2-ylphenyl)phenyl]imidazole;(2-propan-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-(4-propan-2-ylpiperazin-1-yl)methanone;N-propan-2-yl-N-[(1-propan-2-ylazetidin-3-yl)methyl]-3-propan-2-yloxycyclobutan-1-amine;1-propan-2-yl-4-(3-propan-2-ylcyclopentyl)piperazine is sourced from PubChem (CID 167672057), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).